Amedeo's Top 20

Amedeo Smart

Independent Medical Education

07 November 2022

Multidisciplinary Journal Club

  1. Hammond NE, Myburgh J, Seppelt I, Garside T, et al.
    Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis.
    JAMA 2022.

  1. Lagarde D, Kazak L.
    The timing of eating controls energy use.
    Science 2022;378:251-252.

  2. Kjaergaard J, Moller JE, Schmidt H, Grand J, et al.
    Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest.
    N Engl J Med 2022;387:1456-1466.

  3. Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, et al.
    Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations.
    J Clin Oncol 2022.

  4. Green PHR, Paski S, Ko CW, Rubio-Tapia A, et al.
    AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
    Gastroenterology 2022;163:1461-1469.

  1. de Castro G Jr, Kudaba I, Wu YL, Lopes G, et al.
    Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score >/= 1% in the KEYNOTE-042 Study.
    J Clin Oncol 2022.

  2. Gould JF, Makrides M, Gibson RA, Sullivan TR, et al.
    Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 Years.
    N Engl J Med 2022;387:1579-1588.

  3. Camidge DR, Barlesi F, Goldman JW, Morgensztern D, et al.
    Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
    J Clin Oncol 2022.

  4. Alduaij W, Collinge BJ, Ben-Neriah S, Jiang A, et al.
    Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population.
    Blood 2022.

  5. Gallois C, Shi Q, Meyers JP, Iveson T, et al.
    Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.
    J Clin Oncol 2022.

  1. Lee JH, Koutalianos EP, Leimer EM, Bhullar RK, et al.
    Intravenous Lidocaine in Chronic Neuropathic Pain: A Systematic Review.
    Clin J Pain 2022.

  2. Kanis JA, McCloskey EV, Harvey NC, Cooper C, et al.
    The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis.
    Osteoporos Int 2022.

  3. Knueppel P, Bang SH, Troyer C, Barriga A, et al.
    Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE).
    Thromb Res 2022;220:91-96.

  4. de Oliveira RDJ, de Oliveira RG, de Oliveira LC, Santos-Filho SD, et al.
    Effectiveness of whole-body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int 2022.

  5. Stern JI, Chiang CC, Kissoon NR, Robertson CE, et al.
    Narrative review of peripheral nerve blocks for the management of headache.
    Headache 2022;62:1077-1092.

  1. Laredo C, Rodriguez A, Oleaga L, Hernandez-Perez M, et al.
    Adjunct Thrombolysis Enhances Brain Reperfusion following Successful Thrombectomy.
    Ann Neurol 2022.

  2. Hsu JL, Wei YC, Toh CH, Hsiao IT, et al.
    MRI images implicate glymphatic alterations mediate cognitive dysfunction in AD.
    Ann Neurol 2022.

  3. Leibovitzh H, Lee SH, Xue M, Raygoza Garay JA, et al.
    Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
    Gastroenterology 2022;163:1364-1376.e10.

  4. Thorolfsdottir RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al.
    Genetic insight into sick sinus syndrome.
    Eur Heart J 2021;42:1959-1971.

  5. Kim SI, Kim JH, Lee S, Cho H, et al.
    Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis.
    Gynecol Oncol 2022.


more..

Privacy Policy